SCHEMBL7433447

SCHEMBL7433447

CCc1cc(F)ccc1S(N)(=O)=O

nearest known ligand 0.44

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CA2 P00918 4/20 0.42
CA12 O43570 3/20 0.42
CA9 Q16790 3/20 0.42
CA1 P00915 2/20 0.42
PTGES2 Q9H7Z7 11/20 0.42
KDM4E B2RXH2 1/20 0.41
BRD4 O60885 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30507847 0.85 CA2 (0.42) CA2CA12CA9CA1PTGES2
SCHEMBL20133625 0.85 CA2 (0.42) CA2CA12CA9CA1PTGES2
SCHEMBL3277846 0.84 CA2 (0.44) CA2CA12CA9CA1PTGES2
SCHEMBL4118278 0.84 KDM4E (0.44) KDM4ETSHRMAPK1
Hydrochloric Acid SCHEMBL1019715 0.83 CA2 (0.41) CA2CA12CA9CA1PTGES2
SCHEMBL8023270 0.83 PTGS2 (0.50) CA2CA12CA9CA1PTGES2
SCHEMBL14225281 0.82 DDR1 (0.46) KDM4ETSHRMAPK1
SCHEMBL28288866 0.81 HTR2A (0.46) CA2CA12CA9CA1PTGES2
SCHEMBL2808716 0.81 KDM4E (0.41) KDM4ETSHRMAPK1
SCHEMBL3279151 0.80 CA2 (0.43) CA2CA12CA9CA1PTGES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4281073-A1 COMBINATION OF A 3-(IMIDAZOL-4-YL)-4-(AMINO)-BENZENESULFONAMIDE TEAD INHIBITOR WITH AN EGFR INHIBITOR AND/OR MEK INHIBITOR FOR USE IN THE TREATMENT OF LUNG CANCER Ikena Oncology, Inc. (US) 2023-11-29 EP disclosed
CN-117024352-A Novel inhibitors 维沃里翁治疗股份有限公司 2023-11-10 CN disclosed
WO-2022159986-A1 COMBINATION OF A 3-(IMIDAZOL-4-YL)-4-(AMINO)-BENZENESULFONAMIDE TEAD INHIBITOR WITH AN EGFR INHIBITOR AND/OR MEK INHIBITOR FOR USE IN THE TREATMENT OF LUNG CANCER Ikena Oncology, Inc. (US) 2022-07-28 WO disclosed
CN-110088102-A A kind of nitrogen-containing hetero cyclics, preparation method, pharmaceutical composition and application 罗欣药业(上海)有限公司 2019-08-02 CN disclosed
CN-108069958-A A kind of nitrogen-containing hetero cyclics, its preparation method, pharmaceutical composition and application 凯惠科技发展(上海)有限公司 2018-05-25 CN disclosed
EP-3060047-A1 PESTICIDAL COMPOSITIONS AND RELATED METHODS Dow AgroSciences, LLC (US) 2016-08-31 EP disclosed
WO-2015061157-A1 PESTICIDAL COMPOSITIONS AND RELATED METHODS DOW AGROSCIENCES LLC (US) 2015-04-30 WO disclosed
EP-1157024-A1 ACETYLENIC ORTHO-SULFONAMIDO AND PHOSPHINIC ACID AMIDO BICYCLIC HETEROARYL HYDROXAMIC ACIDS AS TACE INHIBITORS American Cyanamid Company (US) 2001-11-28 EP disclosed
WO-2000044749-A1 ACETYLENIC ORTHO-SULFONAMIDO AND PHOSPHINIC ACID AMIDO BICYCLIC HETEROARYL HYDROXAMIC ACIDS AS TACE INHIBITORS AMERICAN CYANAMID COMPANY (US) 2000-08-03 WO disclosed